Jun Zheng

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 10

Top Topics

Community Dwelling

Anti Inflammatory Drugs

Mesenchymal Stem Cells

Signaling Pathway

Top Venues

Medical oncology (Northwood, London, England)

Nature communications

Disease markers

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

This page only lists publications with an associated author ORCID identifier.

Publications

Qiang You, Rong Li, Jia Yao, Ying-Cai Zhang, Xin Sui, Cui-Cui Xiao, Jie-Bin Zhang, Jia-Qi Xiao, Hai-Tian Chen, Hua Li, Jian Zhang, Jun Zheng, Yang Yang
Insights into lenvatinib resistance: mechanisms, potential biomarkers, and strategies to enhance sensitivity. Medical oncology (Northwood, London, England) 41 (3) (2024)
Rong Li, Xijing Yan, Cuicui Xiao, Tingting Wang, Xuejiao Li, Zhongying Hu, Jinliang Liang, Jiebin Zhang, Jianye Cai, Xin Sui, Qiuli Liu, Manli Wu, Jiaqi Xiao, Haitian Chen, Yasong Liu, Chenhao Jiang, Guo Lv, Guihua Chen, Yingcai Zhang, Jia Yao, Jun Zheng, Yang Yang
FTO deficiency in older livers exacerbates ferroptosis during ischaemia/reperfusion injury by upregulating ACSL4 and TFRC. Nature communications 15 (1) (2024)
Rong Li, Xijing Yan, Cuicui Xiao, Tingting Wang, Xuejiao Li, Zhongying Hu, Jinliang Liang, Jiebin Zhang, Jianye Cai, Xin Sui, Qiuli Liu, Manli Wu, Jiaqi Xiao, Haitian Chen, Yasong Liu, Chenhao Jiang, Guo Lv, Guihua Chen, Yingcai Zhang, Jia Yao, Jun Zheng, Yang Yang
FTO deficiency in older livers exacerbates ferroptosis during ischaemia/reperfusion injury by upregulating ACSL4 and TFRC. Nature communications 15 (1) (2024)
Qiang You, Rong Li, Jia Yao, Ying-Cai Zhang, Xin Sui, Cui-Cui Xiao, Jie-Bin Zhang, Jia-Qi Xiao, Hai-Tian Chen, Hua Li, Jian Zhang, Jun Zheng, Yang Yang
Insights into lenvatinib resistance: mechanisms, potential biomarkers, and strategies to enhance sensitivity. Medical oncology (Northwood, London, England) 41 (3) (2024)
Qiang You, Rong Li, Jia Yao, Ying-Cai Zhang, Xin Sui, Cui-Cui Xiao, Jie-Bin Zhang, Jia-Qi Xiao, Hai-Tian Chen, Hua Li, Jian Zhang, Jun Zheng, Yang Yang
Insights into lenvatinib resistance: mechanisms, potential biomarkers, and strategies to enhance sensitivity. Medical oncology (Northwood, London, England) 41 (3) (2024)
Rong Li, Xijing Yan, Cuicui Xiao, Tingting Wang, Xuejiao Li, Zhongying Hu, Jinliang Liang, Jiebin Zhang, Jianye Cai, Xin Sui, Qiuli Liu, Manli Wu, Jiaqi Xiao, Haitian Chen, Yasong Liu, Chenhao Jiang, Guo Lv, Guihua Chen, Yingcai Zhang, Jia Yao, Jun Zheng, Yang Yang
FTO deficiency in older livers exacerbates ferroptosis during ischaemia/reperfusion injury by upregulating ACSL4 and TFRC. Nature communications 15 (1) (2024)
Xijing Yan, Jinliang Liang, Xuejiao Li, Zhongying Hu, Jiahao Chen, Jun Zheng, Rong Li
Identify Key Genes Correlated to Ischemia-Reperfusion Injury in Aging Livers. Disease markers 2023 (2023)
Xijing Yan, Jinliang Liang, Xuejiao Li, Zhongying Hu, Jiahao Chen, Jun Zheng, Rong Li
Identify Key Genes Correlated to Ischemia-Reperfusion Injury in Aging Livers. Disease markers 2023 (2023)
Xijing Yan, Haoyuan Yu, Jinliang Liang, Zhongying Hu, Xuejiao Li, Huanyi Liu, Jia Yao, Xin Sui, Jun Zheng, Rong Li
Synergistic antitumor efficacy of aspirin plus lenvatinib in hepatocellular carcinoma via regulating of diverse signaling pathways. Cell death discovery 9 (1) (2023)
Jun Zheng, Tongyu Lu, Chaorong Zhou, Jianye Cai, Xiaomei Zhang, Jinliang Liang, Xin Sui, Xiaoyan Chen, Liang Chen, Yao Sun, Jiebin Zhang, Wenjie Chen, Yingcai Zhang, Jia Yao, Guihua Chen, Yang Yang
Extracellular Vesicles Derived from Human Umbilical Cord Mesenchymal Stem Cells Protect Liver Ischemia/Reperfusion Injury by Reducing CD154 Expression on CD4+ T Cells via CCT2. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 7 (18) (2020)